Den Baksteen SA
Den Baksteen reported total assets of €1.73m at the end of the 2026 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Den Baksteen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +12 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 16 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Den Baksteen's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 14 Jul 2026
- Year ended 31 Mar 2025filed on 15 Jul 2025
- Year ended 31 Mar 2024filed on 28 Jun 2024
- Year ended 31 Mar 2023filed on 19 Jul 2023
- Year ended 31 Mar 2022filed on 06 Jul 2022
Den Baksteen's financial analysis
- Solvency33.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Den Baksteen
Den Baksteen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0441.068.601
- VAT number
- BE0441068601
- Peppol
- Registered · 0208:0441068601 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 07 Aug 1990
- Registered office
- 1730 Asse
- Latest accounts
- 2026 · filed on 14 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Den Baksteen (SA) has been based in Asse since 1990, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 38,615 € and equity of 579,471 €; its revenue is not published. Its solvency stands at 33.4%, below the median of its sector (44.2%).
Companies similar to Den Baksteen
Companies in the same business, of comparable size and area, outside its group.
- Inge Thoelen Retail sale of pharmaceutical products Landen · balance sheet €1.74m
- Apotheek Hasseltsepoort Retail sale of pharmaceutical products Diest · balance sheet €1.74m
- Apelec Retail sale of pharmaceutical products Zemst · balance sheet €1.74m
- Mooy Pharma Retail sale of pharmaceutical products Veurne · balance sheet €1.74m
- Pharmacie Charue Retail sale of pharmaceutical products Fleurus · balance sheet €1.76m
- Pharma City 2 Retail sale of pharmaceutical products Brussels · balance sheet €1.72m
- Hampharma Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet €1.75m
- Selvais Retail sale of pharmaceutical products Bastogne · balance sheet €1.75m
Frequently asked questions about Den Baksteen
What is the revenue of Den Baksteen?
Den Baksteen files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Den Baksteen?
In Belgium, the VAT number is the company number prefixed with BE: BE0441068601 for Den Baksteen, if the company is VAT-registered. Its company number (CBE) is 0441.068.601.
Where is the registered office of Den Baksteen?
According to the CBE register, the registered office of Den Baksteen is in 1730 Asse.
What is the equity of Den Baksteen?
At the close of the 2026 financial year, the equity of Den Baksteen amounts to 579,471 €, a solvency of 33.4% of total assets.
Who manages Den Baksteen?
The register lists 3 active mandates at Den Baksteen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Den Baksteen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →